Procos raises Eurasian profile at CPhI Istanbul
Press Release | Procos S.p.A.
MAY 27, 2015
Cameri, Italy: – Established Italian contract manufacturer (CMO) Procos will use the upcoming CPhI Istanbul Expo to bring its expanding capabilities to the emerging Turkish and Near Eastern market.
Procos is about to roll out its new 4000 m2 working space workshop, scheduled for completion in Autumn 2015 as a central element in its overall investment and growth strategy, focusing on its principle markets in North America, Europe and Japan as well as ‘pharmarging’ markets in the Near and Far East.
The Procos exhibition at Stand A131E at the ICC Istanbul Congress Center will feature presentations of the company’s sophisticated new facilities, as well as details of its generics contract manufacturing and custom synthesis capabilities.
The new Cameri facility will enable a one third expansion in manufacturing capacity, up to 450m3, as well as new technology platforms to enable more innovative and creative solutions for demanding markets like oncology.
Procos is already a presence in Turkey and is looking to raise its profile further in pharmaceutical markets that are growing apace, leveraging from proximity to Eastern Europe, Near East and North Africa, as well as links into North American and Japanese markets.
Kingo Yamashita, head of Procos’ Sales & Marketing Division, and Clara Usanna (Sales Manager) will lead the team in at CPhI Istanbul.
“This is first time that Procos will be an exhibitor at CPhI Istanbul in our own right,” observed Mr. Yamashita.
“We consider Turkey as one of our key emerging markets. There are some existing projects already, but we would intend to invest more effort into this market.
“Our appearance in Istanbul underlines our strong presence in the Eurasian market,” he added.
“Our combined team there will have interesting offers from our bolstered generic APIs pipeline as well as the new synthesis capabilities we are acquiring from our new workshop,” said Mr. Yamashita.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of APIs and cGMP advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over 70 years, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of APIs and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos’ activities. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantioselective and hazardous chemistry.
About CPhI Istanbul
CPhI Istanbul is the leading pharma industry business and sourcing event for Eurasia, bridging the markets in two continents.
CPhI Istanbul will bring together local Turkish and regional drug manufacturers with global suppliers of raw materials, machinery, packaging solutions and contract services.
Staged by global B2B events organizer and publisher, UBM Live, CPhI Istanbul is a three-day event opening June 3 at the ICC Istanbul Congress Centre, alongside three other zoned exhibitions; P-MEC (including LABWorld) for machinery and equipment, ICSE for outsourcing solutions and InnoPack for Drug Packaging and Delivery Technology.
The events will host 200+ exhibitors and is expected to attract more than 4,000 visitors from the region looking for suppliers and manufacturing partners to bring cost-competitive pharmaceuticals to their individual markets.
CPhI Istanbul offers opportunities to arrange face-to-face meetings with potential international partners and collaborators, as well as gain insights on latest industry trends.
More information at: http://www.cphi.com/japan/home
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211